Microbial composition across body sites in polycystic ovary syndrome: a systematic review and meta-analysis.

Alberto Sola-Leyva, Inmaculada Pérez-Prieto, Nerea M Molina, Eva Vargas, Susana Ruiz-Durán, Irene Leonés-Baños, Analuce Canha-Gouveia, Signe Altmäe

Journal: Reproductive biomedicine online 2023;47(1):129-150

PMID: 37208218

Plain Language Summary

plain language summary logo

Polycystic ovary syndrome (PCOS) is a common hormonal disorder that affects women of childbearing age. The condition is marked by menstrual irregularities, excess levels of androgens (hormones usually dominant in males), and the presence of ovarian cysts. Additionally, it is linked to weight gain, and infertility, as well as an increased risk of developing diabetes and cardiovascular disease. The exact cause of PCOS remains unclear due to its complex nature. Emerging research suggests a potential connection between the microbiome and PCOS. As the human microbiome influences hormone metabolism, it has been postulated that changes in microbial composition could contribute to the development and manifestation of the condition. Yet, due to the variability in influencing factors, it has not been easy to compare studies and find clear links. Hence this review and meta-analysis sought to update current evidence regarding microbial composition in women with PCOS. It included 34 studies that had gathered data on microbial composition from the mouth, blood, gut, and reproductive tract of women with PCOS. But due to a shortage of suited studies, the meta-analyse ended up focusing primarily on the gut. Overall, women with PCOS had significantly less microbial diversity. Specifically in the gut the data indicated that certain bacteria types were increased, such as Prevotella, Shigella, and Escherichia, while beneficial bacteria like Lactobacilli and Bifidobacteria decreased. Similarly, in the vaginal microbiome, species associated with reproductive pathologies were increased, such as Gardnerella and Prevotella, and a reduction in beneficial Lactobacilli. The authors suggested that through many pathways such observed dysbiosis may contribute to the pathologies of PCOS. They stressed that while there is growing evidence linking microbial composition to PCOS, many microbiome studies lack rigorous design and consideration of other influencing factors that alter the microbiome. More well-designed research is needed.

Abstract

Polycystic ovary syndrome (PCOS) is an endocrine disorder affecting reproductive-aged women, but the cause remains unclear. Recent evidence has linked microbial composition with PCOS; however, the results are inconsistent. The aim of this systematic review was to gather current knowledge of the microbes across body sites (oral cavity, blood, vagina/cervix, gut) in women with PCOS, and meta-analyse the microbial diversity in PCOS. For this purpose, a systematic search using PubMed, Web of Science, Cochrane and Scopus was carried out. After selection, 34 studies met the inclusion criteria. Most of the studies associated changes in the microbiome with PCOS, whereas heterogeneity of the studies in terms of ethnicity, body mass index (BMI) and methodology, among other confounders, made it difficult to corroborate this relationship. In fact, 19 out of 34 of the studies were categorised as having high risk of bias when the quality assessment was conducted. Our meta-analysis on the gut microbiome of 14 studies demonstrated that women with PCOS possess significantly lower microbial alpha diversity compared with controls (SMD = -0.204; 95% CI -0.360 to -0.048; P = 0.010; I = 5.508, by Shannon Index), which may contribute to the development of PCOS. Nevertheless, future studies should specifically overcome the shortcomings of the current studies by through well planned and conducted studies with larger sample sizes, proper negative and positive controls and adequate case-control matching.

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Address: Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Systems Biology Unit, Department of Experimental Biology, Faculty of Experimental Sciences, University of Jaén, Jaén, Spain.; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; UGC Obstetricia y Ginecología. HU Virgen de las Nieves, Granada, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Department of Physiology, Faculty of Veterinary, University of Murcia, Campus Mare Nostrum, IMIB-Arrixaca, 30100 Murcia, Spain.; Department of Biochemistry and Molecular Biology, Faculty of Sciences, University of Granada, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain; Division of Obstetrics and Gynaecology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.